×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

ZENITH GRABS MORE SCHERING-PLOUGH BUSINESS

Published on .

(July 19, 2001) -- Schering-Plough Corp. today awarded Cordiant Communications Group's Zenith Media, New York, its estimated $80 million buying account for its consumer health care products, a company spokesman said.

The account includes products such as Coppertone, Afrin, Lotrimin, Tinactin and Dr. Scholl's.

The decision came after a review that included Havas Advertising's Media Planning Group, New York, and independent Horizon Media, New York.

Zenith also handles Schering's $170 million-plus direct-to-consumer pharmaceutical account, which includes Claritin. The incumbent was TN Media, New York. -- David Goetzl

Copyright July 2001, Crain Communications Inc.

In this article:
Most Popular